| Application | Recommended Dilution |
|---|---|
| FC | 1:50-1:200 |
LY6G6D belongs to the lymphocyte antigen 6 superfamily, a group of GPI-anchored cell surface proteins implicated in immune cell signaling and differentiation. Also known as MEGT1 (megakaryocyte-enhanced gene transcript 1 protein), LY6G6D has garnered attention for its potential roles in hematopoietic cell biology and as an emerging target in oncology research, where its expression patterns may serve as markers for specific cell populations or disease states.
This recombinant monoclonal antibody, clone 2D6, offers the reproducibility and sequence-defined consistency that demanding experimental workflows require. Produced in mouse as an IgG2b isotype and purified by affinity chromatography, this antibody eliminates the lot-to-lot variability inherent in traditional hybridoma-derived reagents, ensuring your results remain comparable across extended studies.
Functional ELISA validation demonstrates robust binding activity across multiple species, with confirmed reactivity to human, mouse, rat, and Macaca fascicularis LY6G6D proteins. The antibody shows particularly strong affinity for human LY6G6D, with EC50 values in the low nanogram per milliliter range. Flow cytometry validation further confirms performance in cell-based applications, with clear discrimination between untransfected and LY6G6D-transfected cells demonstrated in both HEK293T and CT26 cell lines at 2 μg per million cells.
This cross-species reactivity makes the antibody especially valuable for translational research programs requiring validation across preclinical models and human samples. Whether investigating LY6G6D in immune cell characterization, megakaryocyte biology, or tumor immunology contexts, this antibody provides a reliable tool for flow cytometry and ELISA-based detection strategies.
Email: support@cusabio.com
Distributors Worldwide